Skip to content
Open access

Metabolomics highlights cardiovascular risk factor links to sphingolipid and one-carbon metabolism in asymptomatic adults

Sep 2026 · bioRxiv · 0 citations · 70 references
Biology

TL;DR

Serine depletion by increased demands of sphingolipid, and possibly transsulfuration pathway, metabolism is associated with elevations in cytotoxic deoxyceramides and reductions in glycine and methionine availability for one-carbon metabolism, a key marker of residual CVD risk.

Abstract

Background Metabolic perturbations associated with cardiovascular disease (CVD) risk factors prior to clinical disease manifestation may inform novel preventative measures. Here we characterize metabolome-wide associations with various cardiometabolic risk factors in an asymptomatic population to develop a mechanistic metabolic framework of preemergent metabolic shifts. Methods Plasma was collected from a clinically healthy cross-sectional cohort (n = 361; Clinical Trials.gov ID: NCT02367287). Cohort mass spectrometry-based metabolomics (biocrates MxP® Quant 500 kits) were complemented with expanded lipidomic coverage for a sex/age-matched subset with LDLc difference > 60 mg/dL (n = 38). LDLc-focused partial least square regressions and discriminate analyses were performed, after false discovery rate corrections. Results As LDLc levels increased, plasma sphingolipids and cholesteryl esters, and transulfuration products were higher, while ether-linked phosphatidylcholines serine, glycine, alanine, methionine were lower. The subset analysis further highlighted elevations in triglycerides and deoxyceramides with elevated LDLc. When adjusted for alanine concentrations, deoxyceramide concentrations increased as serine declined (p = 0.0012), and the deoxyceramide:ceramide ratios were higher in the high LDLc group (p = 0.039). Lower serine levels were also accompanied by parallel changes in glycine (p= 0.0004), and anti-parallel changes in transsulfuration pathway metabolites particularly when adjusted for ceramide levels. Notably, the alanine:serine ratio was more strongly associated with fasting triglycerides (r = 0.38; p <0.0001) than LDLc. Conclusions Serine depletion by increased demands of sphingolipid, and possibly transsulfuration pathway, metabolism is associated with elevations in cytotoxic deoxyceramides and reductions in glycine and methionine availability for one-carbon metabolism. These changes were strongly associated with fasting triglycerides and insulin resistance, a key marker of residual CVD risk.

Read PDF

Similar papers

Open access Aug 2026

Comprehensive NMR metabolomic profiling reveals a pro-atherogenic signature in psoriasis

It can be concluded that psoriasis is associated with coordinated disturbances across lipid, fatty-acid, and amino-acid pathways, reflecting a systemic pro-atherogenic and pro-inflammatory environment.

A. Ottas, M. Karu, L. Ilves et al. · 0 citations
Open access Aug 2026

Targeted Quantitative Metabolomics and Lipidomics Reveal Dysregulated Metabolic Networks and a Serum Candidate Biomarker for Atrial Fibrillation

Background: Atrial fibrillation (AF) is the most prevalent clinical arrhythmia with severe cardiovascular complications, yet its metabolic molecular mechanisms remain poorly defined. Omics-based metabolic profiling provides a powerful strategy to systematically decode AF-associated metabolic disorders. Methods: In this...

Yu-Qing Zhang, Yun-Peng Xie, Xin-Yu Liu et al. · 0 citations
Open access Sep 2026

Serum legacy and emerging PFAS and lipid biomarkers in patients with chronic coronary syndrome: a cross-sectional human biomonitoring study.

Per- and polyfluoroalkyl substances (PFAS) have been associated with altered lipid metabolism in general populations, but evidence remains limited among patients with established coronary artery disease, particularly for emerging PFAS replacement compounds. We conducted a cross-sectional study of 155 patients with chro...

Chen-Yang Wang, Sheng Liu, Si-Yao Ni et al. · 0 citations
Open access Aug 2026

Metabolomics reveals lipid and amino acid signatures of disease severity in multiple sclerosis

Findings highlight coordinated dysregulation of amino acid and lipoprotein metabolism as hallmarks of established MS and identify a novel association of the omega-6/omega-3 ratio with inflammatory disease activity.

Rachel E. Rodin, B. Healy, Mariann Polgár-Turcsányi et al. · 0 citations
Open access Sep 2026

A six-metabolite signature characterizes metabolically unhealthy obesity and reveals hidden metabolic risk within metabolically healthy obesity

Background/objectives Metabolically healthy obesity (MHO) is commonly defined by the absence of metabolic syndrome-related abnormalities despite obesity. However, conventional clinical definitions may overlook substantial metabolic heterogeneity and hidden cardiometabolic risk. We aimed to identify metabolomic signatur...

Pan Gao, Mei-Fang Liang, Bin-Feng Tang et al. · 0 citations
Review Open access Sep 2026

Metabolomics profile in diabetes and blood glucose regulation: a systematic review

Introduction Diabetes mellitus is a chronic, non-communicable metabolic disorder of global public health concern. Many studies utilize metabolomics to profile metabolites in individuals with diabetes. However, these studies have shown inconsistencies in identifying metabolite signatures associated with the disease with...

Aishat O. Adejoh, Queen S. Abbah, John O. Onuh · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.